Related Experiment Videos
Group G streptococcal endocarditis and bacteraemia--a report of 3 cases
Singapore Medical Journal
|October 1, 1990
Insights
Group G Streptococcal infections can cause severe endocarditis and septicaemia, particularly in patients with underlying cardiac conditions. Prompt treatment with intravenous penicillin effectively resolved these serious streptococcal infections.
Area of Science:
- Infectious Diseases
- Cardiology
- Microbiology
Background:
- Group G Streptococcus is an emerging pathogen causing invasive infections.
- Endocarditis and septicaemia are life-threatening conditions often associated with underlying comorbidities.
- Cardiac disease is a significant risk factor for severe streptococcal infections.
Observation:
- Three cases of invasive Group G Streptococcal infection were identified.
- Patients presented with endocarditis and septicaemia.
- All patients had pre-existing cardiac conditions; one also had diabetes mellitus and colonic carcinoma.
Findings:
- Intravenous crystalline penicillin was administered to all three patients.
- All patients demonstrated a positive clinical response to penicillin therapy.
- Penicillin proved effective in treating severe Group G Streptococcal infections in this cohort.
Implications:
- Highlights the potential severity of Group G Streptococcal infections.
- Reinforces the efficacy of penicillin in treating these invasive infections.
- Suggests the importance of considering Group G Streptococcus in patients with cardiac disease and sepsis.
Abstract:
Three patients with Group G Streptococcal infection presenting with endocarditis and septicaemia are reported. All had underlying cardiac disease, and one had diabetes mellitus and a colonic carcinoma. Our three patients responded to intravenous crystalline penicillin.